GW Pharmaceuticals (NASDAQ: GWPH) is a crossbreed: a biotech and a cannabis company. Based in England and founded in 1998, the company's focus is examining various cannabinoid formulations as potential therapeutics. GW Pharmaceuticals's biggest drug is Epidiolex, a liquid, purified form of cannabidiol (CBD). Read More...
GW Pharmaceuticals (NASDAQ: GWPH) is a crossbreed: a biotech and a cannabis company. Based in England and founded in 1998, the company’s focus is examining various cannabinoid formulations as potential therapeutics. GW Pharmaceuticals’s biggest drug is Epidiolex, a liquid, purified form of cannabidiol (CBD).
Add Comment